Read More 1 minute read M&A News News Edwards Lifesciences Sells Critical Care Product Group to BD for $4.2 Billion Key Highlights Edwards Lifesciences sells Critical Care group to BD for $4.2 billion. Transaction enhances Edwards’ focus on… byChris-Anne RoqueJune 4, 2024
Read More 1 minute read M&A News News Pharmaceutical Incyte Completes Acquisition of Escient Pharmaceuticals Key Highlights Incyte acquires Escient Pharmaceuticals for $750 million plus net cash. Acquisition includes EP262 and EP547, first-in-class MRGPR antagonists. Enhances Incyte’s Inflammation and Autoimmunity portfolio. Potential treatments… byChris-Anne RoqueMay 30, 2024